ARTIVION INC (AORT) Stock Fundamental Analysis
NYSE:AORT - New York Stock Exchange, Inc. - US2289031005 - Common Stock - Currency: USD
Taking everything into account, AORT scores 4 out of 10 in our fundamental rating. AORT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AORT get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, AORT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
AORT had negative earnings in the past year.
In the past year AORT had a positive cash flow from operations.
AORT had negative earnings in each of the past 5 years.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.70%, AORT is doing good in the industry, outperforming 68.45% of the companies in the same industry.
AORT has a Return On Equity of -7.26%. This is in the better half of the industry: AORT outperforms 69.52% of its industry peers.
With a decent Return On Invested Capital value of 2.26%, AORT is doing good in the industry, outperforming 69.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.7% | ||
| ROE | -7.26% | ||
| ROIC | 2.26% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT's Operating Margin of 5.41% is fine compared to the rest of the industry. AORT outperforms 71.66% of its industry peers.
AORT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 63.94%, AORT is in the better half of the industry, outperforming 65.78% of the companies in the same industry.
AORT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.41% | ||
| PM (TTM) | N/A | ||
| GM | 63.94% |
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
The number of shares outstanding for AORT has been increased compared to 1 year ago.
AORT has more shares outstanding than it did 5 years ago.
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
AORT has an Altman-Z score of 2.43. This is not the best score and indicates that AORT is in the grey zone with still only limited risk for bankruptcy at the moment.
AORT has a better Altman-Z score (2.43) than 62.03% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that AORT has dependencies on debt financing.
AORT has a Debt to Equity ratio of 1.08. This is in the lower half of the industry: AORT underperforms 79.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.43 |
ROIC/WACC0.26
WACC8.68%
2.3 Liquidity
AORT has a Current Ratio of 5.53. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.53, AORT is doing good in the industry, outperforming 79.68% of the companies in the same industry.
AORT has a Quick Ratio of 3.95. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.95, AORT is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.53 | ||
| Quick Ratio | 3.95 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -42.86% in the last year.
Looking at the last year, AORT shows a small growth in Revenue. The Revenue has grown by 5.94% in the last year.
AORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.06% yearly.
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.67%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%1.59%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.07% yearly.
AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.26% yearly.
EPS Next Y126.49%
EPS Next 2Y75.07%
EPS Next 3Y51.75%
EPS Next 5Y46.07%
Revenue Next Year9.01%
Revenue Next 2Y9.7%
Revenue Next 3Y10.22%
Revenue Next 5Y11.26%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 67.14, which means the current valuation is very expensive for AORT.
AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 65.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, AORT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 67.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than the industry average as 68.98% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 35.87 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AORT's earnings are expected to grow with 51.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.07%
EPS Next 3Y51.75%
5. Dividend
5.1 Amount
AORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.75
-0.35 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners90.63%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner Change11.86%
Market Cap1.31B
Analysts86.67
Price Target33.37 (8.52%)
Short Float %4.05%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-222.77%
Min EPS beat(2)-537.25%
Max EPS beat(2)91.71%
EPS beat(4)2
Avg EPS beat(4)-133.26%
Min EPS beat(4)-537.25%
Max EPS beat(4)91.71%
EPS beat(8)5
Avg EPS beat(8)-81.69%
EPS beat(12)8
Avg EPS beat(12)-43.69%
EPS beat(16)10
Avg EPS beat(16)-60.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.61%
Min Revenue beat(2)-5.37%
Max Revenue beat(2)2.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.16%
Revenue beat(8)5
Avg Revenue beat(8)0.88%
Revenue beat(12)7
Avg Revenue beat(12)0.57%
Revenue beat(16)10
Avg Revenue beat(16)6.83%
PT rev (1m)1.18%
PT rev (3m)1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-299.4%
EPS NY rev (1m)15.52%
EPS NY rev (3m)569.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 67.14 | ||
| P/S | 3.37 | ||
| P/FCF | N/A | ||
| P/OCF | 121.85 | ||
| P/B | 4.46 | ||
| P/tB | N/A | ||
| EV/EBITDA | 35.87 |
EPS(TTM)-0.5
EYN/A
EPS(NY)0.46
Fwd EY1.49%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.25
OCFY0.82%
SpS9.14
BVpS6.89
TBVpS-2.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.7% | ||
| ROE | -7.26% | ||
| ROCE | 2.86% | ||
| ROIC | 2.26% | ||
| ROICexc | 2.38% | ||
| ROICexgc | 5.55% | ||
| OM | 5.41% | ||
| PM (TTM) | N/A | ||
| GM | 63.94% | ||
| FCFM | N/A |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.89%
ROICexcg growth 5Y4.3%
ROICexc growth 3Y45.07%
ROICexc growth 5Y7.68%
OM growth 3Y31.35%
OM growth 5Y5.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.08 | ||
| Cap/Depr | 47.24% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 24.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.53 | ||
| Quick Ratio | 3.95 | ||
| Altman-Z | 2.43 |
F-Score4
WACC8.68%
ROIC/WACC0.26
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.67%
EPS Next Y126.49%
EPS Next 2Y75.07%
EPS Next 3Y51.75%
EPS Next 5Y46.07%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%1.59%
Revenue Next Year9.01%
Revenue Next 2Y9.7%
Revenue Next 3Y10.22%
Revenue Next 5Y11.26%
EBIT growth 1Y-9.27%
EBIT growth 3Y43.36%
EBIT growth 5Y12.95%
EBIT Next Year107.33%
EBIT Next 3Y42.09%
EBIT Next 5Y33.37%
FCF growth 1Y97.95%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y200.63%
OCF growth 3YN/A
OCF growth 5Y7.04%